Balchem BCPC Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Net Sales by Business | ||||||
| Animal Nutrition and Health | $62.19M+8.6% | $61.17M+4.9% | $56.38M+6.6% | $56.03M+13.1% | $57.28M+6.2% | |
| Human Nutrition and Health | $171.63M+8.3% | $166.07M+12.7% | $174.09M+14.3% | $160.77M+8.7% | $158.46M+3.7% | |
| Specialty Products | $34.73M+4.4% | $34.83M+6.0% | $35.68M+7.5% | $37.19M+6.0% | $33.28M+5.3% | |
| Operating Income (Loss) by Business | ||||||
| Animal Nutrition and Health | $5.69M+8.7% | $6.22M+8.6% | $3.71M+5.2% | $3.51M+30.5% | $5.24M+154% | |
| Human Nutrition and Health | $40.02M+5.4% | $36.76M+8.9% | $40.83M+14.8% | $38.34M+14.9% | $37.97M+14.2% | |
| Specialty Products | $11.94M+24.5% | $10.51M+5.5% | $11.53M+9.7% | $11.27M+0.4% | $9.59M+16.9% | |
| Gross Profit by Business | ||||||
| Animal Nutrition and Health | $14.99M+21.3% | $14.91M+13.1% | $11.75M+10.3% | $11.54M+18.0% | $12.36M+27.6% | |
| Human Nutrition and Health | $65.86M+11.5% | $59.78M+8.1% | $64.13M+13.6% | $61.31M+12.1% | $59.07M+6.7% | |
| Specialty Products | $20.46M+18.4% | $19.51M+6.5% | $19.95M+5.8% | $20.61M+7.8% | $17.29M+1.8% | |
| Operating expenses by Business | ||||||
| Animal Nutrition and Health | $9.3M+30.5% | $8.69M+16.6% | $8.03M+12.8% | $8.03M+13.2% | $7.12M-6.6% | |
| Human Nutrition and Health | $25.84M+22.4% | $23.02M+6.8% | $23.3M+11.6% | $22.96M+7.6% | $21.1M-4.5% | |
| Specialty Products | $8.53M+10.7% | $9M+7.6% | $8.41M+0.9% | $9.35M+18.3% | $7.7M-12.4% | |
| Total Assets by Business | ||||||
| Animal Nutrition and Health | $181.04M+6.8% | $176.61M+9.5% | $171.85M+10.9% | $173.19M+11.1% | $169.46M+6.6% | |
| Human Nutrition and Health | $1.25B+3.1% | $1.24B+4.9% | $1.23B+4.1% | $1.25B+6.4% | $1.21B+2.4% | |
| Specialty Products | $169.77M+1.8% | $172.08M+6.7% | $172.5M+3.4% | $174.21M+4.8% | $166.75M-0.3% | |
| Cost of Sales by Business | ||||||
| Animal Nutrition and Health | $47.2M+5.1% | $46.26M+2.5% | $44.63M+5.6% | $44.49M+11.8% | $44.92M+1.5% | |
| Human Nutrition and Health | $105.77M+6.4% | $106.29M+15.6% | $109.96M+14.7% | $99.47M+6.7% | $99.38M+2.1% | |
| Specialty Products | $14.26M-10.8% | $15.32M+5.5% | $15.74M+9.7% | $16.57M+3.8% | $15.99M+9.3% | |
| D&A by Business | ||||||
| Animal Nutrition and Health | $1.86M+5.6% | $1.86M-5.5% | $1.83M-11.3% | $1.83M-12.7% | $1.76M-16.2% | |
| Human Nutrition and Health | $8.65M+18.4% | $7.66M+10.3% | $7.62M+11.9% | $7.54M-10.0% | $7.3M-23.4% | |
| Specialty Products | $1.76M+1.7% | $1.97M+13.9% | $1.87M+5.8% | $1.8M+1.8% | $1.73M-3.0% | |
| CapEx by Business | ||||||
| Animal Nutrition and Health | $2.39M+1.9% | $6.89M+45.3% | $5.52M+33.7% | $2.08M-10.0% | $2.34M+16.0% | |
| Human Nutrition and Health | $3.16M+35.6% | $7.14M+24.9% | $8.05M+93.8% | $3.7M+7.6% | $2.33M-45.4% | |
| Specialty Products | $597K-17.3% | $1.86M-11.5% | $1.08M+54.1% | $963K+18.9% | $722K+66.0% | |
| Net Sales by Product | ||||||
| Product Sales Revenue | $270.22M+8.1% | $263.09M+9.8% | $267.08M+11.5% | $255.04M+9.1% | $250.06M+4.6% | |
| Royalty Revenue | $493K+7.6% | $525K+21.8% | $480K+14.8% | $426K+20.0% | $458K-14.1% | |
| Cost of Sales by Product | ||||||
| Raw materials sold | $9.95M+0.3% | $9.34M+9.2% | $9.4M+23.4% | $10.82M+48.2% | $9.93M+56.7% | |
| Services provided | $1.12M-0.9% | $1.19M+8.1% | $1.11M-0.1% | $1.21M+8.2% | $1.13M+3.2% | |
| Net Sales by Geography | ||||||
| Non-US | $73.33M+13.2% | $74.66M+27.7% | $69.49M+19.9% | $68.76M+21.9% | $64.8M+12.5% | |
| United States | $197.38M+6.3% | $188.96M+4.1% | $198.06M+8.8% | $186.71M+5.1% | $185.72M+2.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Balchem break its business down?
- Balchem (BCPC) reports net sales by business across 3 parts — Animal Nutrition and Health, Human Nutrition and Health and Specialty Products. Each is extracted from the segment footnotes and tracked over time.
- Where does Balchem's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Balchem's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
